Stock ORPHA ORPHAZYME A/S
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Orphazyme A/S

Equities

ORPHA

DK0062502894

Delayed Nasdaq Copenhagen
Other stock markets
 15:13:57 16/05/2024 BST 		5-day change 1st Jan Change
1,058 DKK +0.38% Intraday chart for Orphazyme A/S +4.73% -20.47%
03-27 Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-04 FDA Extends Review of Zevra's Arimoclomol by Three Months DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ORPHAZYME A/S
Bio Therapeutic Drugs
+0.38%+4.73%-20.47%-5.72%-98.02% 5.44M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ORPHA Stock
  4. Charts Orphazyme A/S
  5. Comparison Chart